At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Mar 1, 2026 at 19:00 ET
ResMed CEO Michael J. Farrell exercised stock options and sold 4,991 shares in the open market for approximately $1.25 million. The transaction was part of a pre-arranged trading plan and not an outright purchase, with no cash outlay for the exercised shares.
- CEO Michael J. Farrell exercised 9,982 derivative securities in total (two tranches of 4,991 shares), one at $0 and one at $146.34 per share.
- Farrell sold 4,991 shares in the open market at $251.0322 per share, generating $1,252,901.71 in proceeds.
- The exercise at $0 suggests a cashless exercise or option swap, common in pre-arranged plans.
- Total open-market sale value: ~$1.25M, representing 0.0035% of ResMed’s $36.0B market cap, immaterial in scale.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access